Myomo Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 91/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 5.00.In the medium term, the stock price is expected to remain stable.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Myomo Inc's Score
Industry at a Glance
Industry Ranking
91 / 208
Overall Ranking
216 / 4582
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
5
analysts
Buy
Current Rating
5.000
Target Price
+362.96%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Myomo Inc Highlights
StrengthsRisks
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 109.26% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 32.55M.
Fairly Valued
The company’s latest PE is -3.25, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 21.95M shares, decreasing 7.73% quarter-over-quarter.
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.
Ticker SymbolMYO
CompanyMyomo Inc
CEOGudonis (Paul R)
Websitehttps://myomo.com/
FAQs
What is the current price of Myomo Inc (MYO)?
The current price of Myomo Inc (MYO) is 0.928.
What is the symbol of Myomo Inc?
The ticker symbol of Myomo Inc is MYO.
What is the 52-week high of Myomo Inc?
The 52-week high of Myomo Inc is 7.170.
What is the 52-week low of Myomo Inc?
The 52-week low of Myomo Inc is 0.711.
What is the market capitalization of Myomo Inc?
The market capitalization of Myomo Inc is 35.69M.
What is the net income of Myomo Inc?
The net income of Myomo Inc is -6.18M.
Is Myomo Inc (MYO) currently rated as Buy, Hold, or Sell?
According to analysts, Myomo Inc (MYO) has an overall rating of Buy, with a price target of 5.000.
What is the Earnings Per Share (EPS TTM) of Myomo Inc (MYO)?
The Earnings Per Share (EPS TTM) of Myomo Inc (MYO) is -0.287.